Explore how evolving science, expanding global demand, and next-generation innovations are reshaping the future of corticosteroid and hormonal therapies — and what this transformation means for the years ahead.
INSIGHTS ON DRUG DEVELOPMENT
-
Comprehensive Workflow For The Quantification Of Peptides And Proteins
Biologics are transforming medicine, with semaglutide leading the way. Discover how an automated LC-MS/MS workflow enables high-sensitivity quantification of peptides in plasma.
-
Navigating Nitrosamine Impurities In Pharmaceutical Drug Development
Understanding formation mechanisms and potency categorization allows developers to mitigate risks early, ensuring regulatory compliance and patient safety without compromising product performance.
-
The Need For Speed: Early-Stage Dosage Form Development
The right formulation strategy can accelerate clinical timelines and set the stage for successful later-phase development.
-
High Potency APIs And The Evolving Demands Of Drug Development4/13/2026
See how higher API activity is changing expectations around containment, scalability, and cross‑functional alignment — and why early decisions now have a greater impact on long‑term success.
-
Neoantigen-Based Personalized Cancer Vaccine7/1/2026
Personalized cancer vaccines are advancing quickly, but effective delivery remains a major hurdle. Learn how mRNA and lipid nanoparticle design influence targeting, endosomal escape, and repeat dosing.
-
Streamlining Drug Development: From Developability Assessment To High-Concentration Formulation Development6/19/2025
Explore a strategic approach to accelerating biologics formulation by gaining early insight into molecular properties and optimizing high-concentration conditions with minimal protein input.
-
T3P – A Green Solution For Peptide Coupling, Water Removal Reactions1/13/2026
The session focuses on the use of T3P (propanephosphonic acid anhydride) in amidation and peptide coupling reactions, including both liquid-phase and solid-phase peptide synthesis.
-
Evaluating Compound Toxicity Effects On Healthy Intestinal Organoids3/24/2025
3D organoids enhance drug toxicity prediction and are crucial for anti-cancer drug development. Examine a method using 3D mouse intestinal organoids that aims to provide vital data on intestinal toxicity.
DRUG DEVELOPMENT SOLUTIONS
-
MabSelect™ VL affinity resin uses a protein L ligand with strong affinity for the variable region of a human antibody’s kappa light chain. The resin offers high productivity and robust processes for affinity capture of bispecific antibodies and antibody fragments containing the kappa light chain and offers a good capture alternative for antibody variants that does not bind to protein A.
-
Explore a wide variety of DHR temperature systems and accessories, designed for superior performance and ease-of-use.
-
Our combined method development experience ensures that client methods are robust, effective, flexible, innovative and allow true stability indication.
-
Get Systematic Chemical Names for Structures, and Produce Structures from Names
ACD/Name generates chemical names according to IUPAC rules, converts chemical names to structures, and easily handles challenging areas of nomenclature.
- Generate names for organic; biochemical; and some inorganic, organometallic, and polymer structures
- Convert systematic or trivial names to structures
-
By harnessing cutting-edge microcalorimetry technology, researchers can unravel the complexities of molecular interactions, paving the way for groundbreaking discoveries in drug development.